Cargando…
Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study
BACKGROUND: Dexmedetomidine, an alpha(2)-adrenoceptor agonist, has been evaluated as an adjunct to anesthesia and for the delivery of sedation and perioperative hemodynamic stability. It provokes dose-dependent and centrally-mediated sympatholysis. Coronary artery bypass grafting (CABG) with extraco...
Autores principales: | Leino, Kari, Hynynen, Markku, Jalonen, Jouko, Salmenperä, Markku, Scheinin, Harry, Aantaa, Riku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123640/ https://www.ncbi.nlm.nih.gov/pubmed/21605394 http://dx.doi.org/10.1186/1471-2253-11-9 |
Ejemplares similares
-
Highly variable pharmacokinetics of dexmedetomidine during intensive care: a case report
por: Iirola, Timo, et al.
Publicado: (2010) -
Protective effect of dexmedetomidine in coronary artery bypass grafting surgery
por: REN, JIANJUN, et al.
Publicado: (2013) -
The effects of levosimendan on myocardial oxygen consumption and coronary blood flow early after coronary artery bypass grafting
por: Lilleberg, J, et al.
Publicado: (2002) -
Dexmedetomidine-induced diabetes insipidus during coronary artery bypass graft surgery
por: Tang, Tuan, et al.
Publicado: (2023) -
A national survey into perioperative anesthetic management of patients with a fractured neck of femur
por: Soinikoski, Mirka, et al.
Publicado: (2012)